Other languages Abeona Therapeutics Inc.

Equities

Market Closed - Nasdaq Other stock markets 04:00:00 2024-05-28 pm EDT			5-day change	1st Jan Change
4.1 ^USD	+0.99%		-4.87%	-18.16%

May. 16	Cantor Fitzgerald Adjusts Price Target on Abeona Therapeutics to $21 From $36, Maintains Overweight Rating	MT
May. 15	Transcript : Abeona Therapeutics Inc., Q1 2024 Earnings Call, May 15, 2024

Abeona Therapeutics Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	May. 15
Lost in Inflation	May. 15
En Direct des Marchés : Renault, Eiffage, CGG, Sony, Burberry, Novo Nordisk, Google...	May. 15
Borsa di Italia: Inflazione persa	May. 15
Bolsa de Madrid: Perdidos en la inflación	May. 15
Les actions mèmes rugissent à nouveau	May. 14
Borse di Italia: i meme tornano a ruggire	May. 14
En Direct des Marchés : Veolia, Stellantis, BNP Paribas, Bayer, Anglo American, Rheinmetall, Uber...	May. 14
Bolsas de Madrid: Los memes vuelven a rugir	May. 14
Abeona Therapeutics Prices $75 Million Securities Offering; Shares Rise	May. 03
Sector Update: Health Care Stocks Rise Late Afternoon	Apr. 23
Top Midday Decliners	Apr. 23
US FDA declines to approve Abeona's skin disorder treatment	Apr. 22
Abeona Therapeutics Inc. Provides Regulatory Update on Pz-Cel	Apr. 22
Sector Update: Health Care Stocks Edge Up Late Monday Afternoon	Mar. 18
Sector Update: Health Care Stocks Rise Monday Afternoon	Mar. 18
Sector Update: Health Care	Mar. 18
Abeona Therapeutics Shares Fall After 2023 Results, FDA Observations on Cleveland Facility	Mar. 18
Abeona Therapeutics Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 18
Abeona Says FDA Confirms Target Action Date For Pz-cel Application After Inspection	Feb. 01

No results for this search